Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma
, , , , and
Sep 05, 2025
About this article
Published Online: Sep 05, 2025
Page range: 403 - 411
Received: Jun 15, 2025
Accepted: Jul 19, 2025
DOI: https://doi.org/10.2478/raon-2025-0049
Keywords
© 2025 Matic Setina et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Setina, Matic
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Setina, Eva
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Doljak, Ziga
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Goricar, Katja
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Dolzan, Vita
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Kovac, Viljem
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Institute of Oncology LjubljanaLjubljana, Slovenia